•Average
follow-up 37 months (7-66 months)
•Overall
result: 267 (89%) patients with good to excellent results, fair
results 15 (5%) patients (single
level)
•Various
evaluations of response to treatment: modified Mac Nab
criteria, Oswestry disability score/index (ODI), visual
analogue pain scale (VAS), patient satisfaction scoring, pain diagram
and/or patient target achievement score (PTA) for assessment
were utilized
•Average
satisfaction score – 281 (93.7%)
•18 (6%)
patients had mild residual pain and parasthesia, although
overall their pain lessened
•Complication
rate: less than 1%